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Abstract A cDNA clone encoding an inwardly-rectifying potas- 
sium channel snbunit (Kit6.2) was isolated from an insnlinoma 
cDNA library. The mRNA is strongly expressed in brain, skeletal 
muscle, cardiac muscle and in insulinoma cells, weakly expressed 
in lung and kidney and not detectable in spleen, liver or testis. 
Heterologous expression of Kir6.2 in HEK293 cells was only 
observed when the cDNA was cotransfected with that of the 
sulphonylurea receptor (SUR). Whole-cell Kir6.2/SUR currents 
were K+-selective, time-independent and showed weak inward 
rectification. They were blocked by external barium (5 raM), 
tolbutamide (K d = 4.5 /tM) or quinine (20 ttM) and by 5 mM 
intracellular ATP. The single-channel conductance was 73 pS. 
Single-channel activity was voltage-independent and was blocked 
by 1 mM intracellular ATP or 0.5 mM tolbutamide. We conclude 
that the Kir6.2ISUR channel complex comprises the ATP-sensi- 
tire K-channel. 
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1. Introduction 
ATP-sensitive K-channels (K-ATP channels) are found in a 
variety of tissues including pancreatic fl-cells, cardiac, smooth 
and skeletal muscle, axons and certain neurones [1,2]. Their 
most characteristic property is that they are inhibited by an 
increase in the intracellular ATP concentration: they thereby 
couple cellular metabolism to changes in transmembrane K-
flux or electrical activity. K-ATP channels play important roles 
in both physiological (insulin secretion) and pathophysiological 
(cardiac and cerebral ischaemia) conditions [1-3]. Sulpho- 
nylureas, a class of drugs used in the treatment of non-insulin- 
dependent diabetes mellitus, act as potent inhibitors of K-ATP 
channels [4]. These drugs act by binding to a specific 
sulphonylurea receptor (SUR), which interacts with the K-ATP 
channel to bring about its closure. Cloning of a 140 kDa high- 
affinity sulphonylurea receptor (SUR) revealed it to be a mem- 
ber of the ATP-binding cassette (ABC) transporter family, with 
2 nucleotide binding folds [5]. This protein does not show chan- 
nel activity when expressed, suggesting SUR alone does nol 
form the K-ATP channel. 
The properties of the K-ATP channel suggest that it may 
belong to the superfamily of inwardly-rectifying potassium 
channels (Kir channels, [6]'). At least six distinct subfamilies of 
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Kir channels have been cloned. Like these cloned channels [6], 
the native K-ATP channel shows inward rectification, little 
time- or voltage-dependence, and is strongly K-selective [1,2]. 
None of the Kir channels cloned to date have a tissue distribu- 
tion similar to that of the native K-ATP channel, suggesting 
that its molecular identity remains to be established. We have 
recently found that both Kir6.1 [7] and K i r l . l a  [8] can couple 
to SUR (unpublished observations), suggesting they may share 
homology with the K-ATP channel. We therefore used these 
as probes to screen a fl-cell cDNA library and isolated a novel 
Kir channel with a tissue distribution and biophysical proper- 
ties corresponding to those of the native K-ATP channel. 
2. Materials and methods 
2.1. Molecular biology 
We prepared a cDNA library from the mouse insulinoma cell line 
M IN6 using a ZAP Express cDNA synthesis kit (Stratagene): the aver- 
age length of insert was 3 kb and the number of independent clones was 
106. This library (5 x 105 phages) was screened at low stringency using 
mixed radiolabeled probes consisting of the full length cDNA of Kir6.1 
and Kir I. la (hybridized at 37°C with 30% formamide and then washed 
at 0.3 x SSC, 0.1% SDS, 42°C for 1 h) and 4 positively hybridizing 
clones were isolated. Each isolated clone was excised using a helper 
phage (ExAssist) and recircularised to form a pBK-CMV vector con- 
taining the insert. Two independent clones were sequenced and found 
Io be identical. 
Total RNA was isolated from MIN6 and RINm5F (rat insulinoma) 
cells using TRI-REAGENT (Molecular Research Centre) and 10 ~g of 
each total RNA, was separated on a 1% agarose-formaldehyde gel,
transferred to a nylon membrane (Hybond-N, Amersham) and hy- 
bridised with Kir6.2 cDNA (entire coding region). We also probed a 
Multiple Tissue Northern Blot (Clonetech) containing 2 ¢tg poly A + 
RNA per lane from various tissues with Kit6.2 cDNA. The blots were 
washed at high stringency (0.1 × SSC, 65°C for 1 2 h) and autoradi- 
ography was carried out for 2 days with intensifying screens. 
2.2. Electrophysiology 
HEK293 cells were transiently transfected with the pBK-CMV vector 
containing the coding sequence of Kir6.2, or hamster SUR ([5], sub- 
cloned into pcDNA3), using lipofectin (Life-Technologies), as de- 
scribed by the manufacturer. In most experiments we cotransfected 
HEK293 cells with Kir6.2 and SUR: the total DNA concentration was 
kept constant in cotransfections and the ratio of Kir6.2 to SUR was 
either 1:1 or 1:4. Mock-transfected cells received the same amount of 
plasmid without coding sequences, but were otherwise treated exactly 
the same. Cells were assumed to express Kir6.2 if their currents were 
larger than 1.96 standard deviations above the mean current (95% 
confidence limits) observed in mock-transfected cells in parallel trans- 
fections. For Kir6.2 + SUR transfected cells, this amounted to 23 out 
of 38 cells dialysed with 0.3 mM ATP and 5/8 cells dialysed with 5 mM 
ATP: only these cells were used for analysis. 
Cells were cultured before and alter transfection i MEM medium, 
supplemented with 10% FCS, 100 U/ml penicillin and 0.1 mg/ml strep- 
tomycin, at 37°C in an atmosphere of humidified air (95%) and CO 2 
15%). Whole-cell and single-channel currents were studied 48 72 h after 
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transfection using the patch clamp technique. For whole-cell record- 
ings, the pipette solution contained (mMl: 107 KC1, 1.2 MgCI2, 1 CaC12, 
10 EGTA, 5 HEPES (pH 7.2 with KOH: total K - 137 raM) and 0.3 mM 
ATP (or 5 mM ATP where indicated). The bath solution contained 
(mM): 40 KCI, 100 NaC1, 2.6 CaCI 2. 1.2 MgCI~, 5 HEPES (pH 7.4). 
Different K concentrations were obtained by equimolar substitution 
with NaCI. The holding potential was -30 mV. For inside-out patch 
recordings, the pipette contained (mM): 140 KCI, 2.6 CaCI 2, 1.2 MgCI~, 
5 HEPES (pH 7.4) and the bath contained (mM): 107 KC1, 1.2 MgCI 2, 
1 CaCI2, 10 EGTA, 5 HEPES (pH 7.2 with KOH; total K ~137 mM) 
plus MgATP and KzADP as indicated. Tolbutamide was dissolved in 
DMSO (final concentration <0.1%). Experiments were carried out at 
22-25°C, 
Drugs were tested once the whole-cell currents had reached asteady- 
state level (> 15 min), with 0.3 mM [ATP]i. Tolbutamide dose-response 
curves were obtained for each cell at all drug concentrations. Test 
solutions were alternated with control solutions and the current (I) is 
plotted as a fraction of the mean (Ic) of that obtained in control solution 
before and after exposure to the drug. Test solutions were applied in 
random order. Dose-response curves were fitted to a modified form of 
the Hill equation: I/It = O + (( l - O)/( l + ([Tolb]/KdY)) where [Tolb] is 
the tolbutamide concentration, Ka is the tolbutamide concentration at
which inhibition is half maximal, n is the Hill coefficient and O is an 
offset which describes the fact that in some cells the maximum block 
was not zero. Data are presented as mean + S.E.M. and vertical lines 
indicate one SEM. Statistical significance was tested using the paired 
t-test. 
Single-channel current recordings were liltered at 0.5 kHz or 2.5 kHz 
(for kinetics) by an 8-pole Bessel filter, and sampled at 1 or 10 kHz using 
a Digidata A/D converter (Axon Instruments). Channel activity was 
calculated as the mean current amplitude divided by the single-channel 
current for data stretches of 1-2 min. Mean open and closed times were 
obtained by fitting the lifetime distributions using a Simplex maximum 
likelihood method. 
3. Results 
A novel clone was isolated by screening a MIN6 cDNA 
library. The nucleotide sequence of this clone (Fig. 1A) predicts 
a protein of 390 amino acids (Mr--43,561), sharing 74% 
homology with Kit6.1 (UKAv P -  1 [7]), 48% with K i r l . la  
(ROMK1 [8]), 50% with Kir2.1 (IRK1 [9]), 49% with Kir3.1 
(GIRK1 [10]), 50% with Kir3.2 (BIR1 [1l]) and 49% with 
Kir3.4 (rcK-ATP [12]). The homology to Kir6.1 suggests that 
this clone belongs to the same subfamily and should be named 
Kir6.2. In particular, like Kir6.1 [7], a GFG motif  is found in 
the putative pore- forming loop instead of the GYG motif 
found in other Kir channels [7 12]. A hydrophobicity plot of 
Kir6.2 reveals two putative transmembrane domains, as found 
for other Kir channels. There are 2 potential cAMP-dependent 
phosphorylation sites (Thr-224 and Ser-372), 6 potential pro- 
tein kinase C-dependent phosphorylation sites (Ser-3, Ser-37, 
Thr-190, Thr-336, Thr-345 and Ser-363) and 3 potential casein 
kinase II-dependent phosphorylation sites (Thr-62, Thr-224 
and Ser-354). There is no obvious nucleotide consensus e- 
quence for ATP-binding. 
The tissue distribution of Kir6.2 mRNA is illustrated in Fig. 
lB. Northern blot analysis showed two transcripts of 2.9 and 
4.0 kilobases. These were strongly expressed in skeletal muscle, 
heart, brain and the insulinoma cells MIN6 and RINm5F. 
Weak expression was found in lung, very weak expression in 
kidney and no hybridization was detected in spleen, liver or 
testis. 
HEK293 cells were transfected with Kir6.2. or cotransfected 
with Kit6.2 and SUR, cDNA and whole-cell currents examined 
using the standard configuration of the patch clamp method 
with 0.3 mM [ATP]~. No difference was observed in the ampli- 
tude of whole-cell currents recorded in mock-transfected and 
Kir6.2 transfected cells, which were -249 + 32 pA (n = 63) 
compared to -262 _+ 66 pA (n = 25), respectively, at -100 inV. 
This suggests Kir6.2 does not express in HEK293 cells. In cells 
transfected with SUR alone the current amplitude was 
-291 + 53 pA (n = 41) at -100 mV, which is not significantly 
different from mock-transfected cells and confirms that SUR 
does not itself form an ion channel. When cells were cotrans- 
fected with Kir6.2 and SUR, however, whole-cell currents were 
initially larger than in mock-transfected cells (-743 + 165 pA) 
and further increased to -2621 _+ 460 pA (n --- 12, P < 0.001), 
at -100 mV, within the next 15 rain (Fig. 2A). A similar effect 
is found in pancreatic fl-cells where it has been attributed to the 
washout of ATP from the cell following dialysis with the pipette 
solution [13]. No such increase in current was observed over a 
15 min period in mock-transfected cells, Kir6.2-transfected cells 
or SUR-transfected cells; or when cells cotransfected with 
Kir6.2 + SUR were dialysed with 5 mM ATP, current ampli- 
tudes at -100 mV being -659 + 56 pA at 0 rain and -564 + 105 
pA at 10 min (n = 5), This indicates that Kir6.2/SUR currents 
are inhibited by intracellular ATE 
Fig. 2B,C shows whole-cell currents and the associated cur- 
rent-voltage (I-V) relationship from a cell cotransfected with 
Kir6.2 and SUR. Currents activated instantaneously upon hy- 
perpolarization, were time-independent and showed weak in- 
ward rectification, properties which are characteristic of native 
K-ATP channels [1,2]. The Kir6.2/SUR currents reversed at 
-23.7 + 1.4 mV (n = 6) in 40 mM external K ÷. Reduction of 
[K+]c, decreased the slope conductance and shifted the reversal 
potential to more negative potentials (Fig. 2D). The shift in the 
reversal potential was 45.2 + 3.2 mV (n = 6) for a 10-fold 
change in [K+]0 (Fig. 2E), indicating that the channel is highly 
K-selective. 
The pharmacology of Kir6.2/SUR currents was consistent 
with that of native K-ATP channels. Thus, 5 mM barium 
blocked the current in a time- and voltage-dependent manner, 
the current being blocked by 74.9 + 10.6% (n = 7, P < 0.01) at 
-100 mV (Fig. 3A,D). Quinine (20/IM) inhibited Kir6.2/SUR 
currents by 68.9 + 10.9% (n -- 5, P < 0.02) at -100 mV (Fig. 
3D), a potency consistent with that of native K-ATP channels 
[14]. Tolbutamide (0.5 mM) also blocked Kir6.2/SUR currents 
(Fig. 3B), by 68.7 + 7.9% at -100 mV (n = 14, P < 0.01; Fig. 
3D). A representative dose-response curve for tolbutamide in- 
hibition is shown in Fig 3C and was fitted best with a Kd = 2.4 
/ IM and a Hill coefficient of 1.04: mean values were 4.2 + 1.4 
/ IM and 0.91 + 0.21/tM (n = 5), respectively. These values are 
similar to those found for K-ATP currents in pancreatic fl-cells 
[1,2,4,13]. 
Fig. 4A shows single-channel currents recorded from an in- 
side-out patch on a HEK293 cell cotransfected with Kir6.2 and 
SUR. At negative potentials, channel openings were clustered 
into bursts separated by long closed periods, whereas openings 
of longer duration were found for outward currents. During the 
burst, the mean open and closed times were 1.51 + 0.27 ms and 
0.38 + 0.05 ms (n -- 6) at -70 mV, respectively. There was no 
clear dependence of the open probability on membrane poten- 
tial. The current-voltage r lationship (Fig. 4B) showed weak 
inward rectification, the currents at +30 mV being ~53 + 7% 
(n = 5) of those at -30 mV, and the mean single-channel con- 
ductance, measured over the linear part of the I -V  relationship 
(from -10 to -70 mV), was 72.5 + 2.2 pS (n = 8). In inside-out 
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Fig. 1. (A) Predicted amino acid sequence of Kir6.2 and comparison with other members of the inward rectifier family. Residues shared with at least 
Kir6.2 are boxed; putative transmembrane (TM) and pore (H5) domains are overlined. Dashes represent minimal gaps introduced to maximize the 
comparison. (B) Tissue distribution of Kir6.2. Left: Poly A + RNA (2/~g/lane) from the specified tissues was hybridised with Kir6.2. Right: Total 
RNA (10 ,ug/lane) was extracted from MIN6 cells or RINm5F cells and hybridised with Kir6.2. 
patches,  s ingle-channel  currents were inhibited by appl icat ion 
o f  1-5 mM ATP  (Fig. 4C and 3 othersj  or 0.5 mM to lbutamide 
(Fig. 4D) .  All  these propert ies are characterist ic of  native K- 
ATP channels.  
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Fig. 2. (A) Whole-cell currents recorded from a HEK293 cell cotransfected with eDNA encoding Kir6.2 and SUR in response to alternate 20 mV 
depolarizing or hyperpolarizing pulses from a holding potential o f -30 mV. (B,C) Whole-cell currents (B) and corresponding current voltage (~V) 
relationship (C) recorded from a HEK293 cell cotransfected with Kir6.2 and SUR, in response to a series of voltage steps from -150 to +130 mV 
from a holding potential of -30 mV. (D) Current voltage (~V) relationships recorded for the same cell in 40 mM K (o), 20 mM K (..) and 5.6 mM 
K (o) solution. Holding potential, -30 inV. (E) Mean relationship between the current reversal potential and [K]~, for 6 cells. The line has a slope 
of 45 mV per decade change in [Klan. 
Single-channel currents were observed in 19/35 inside-out 
patches and at higher frequency in cell-attached patches (> 80% 
of patches in some transfections). In most cases more than one 
channel was found in each patch. A channel with similar kinet- 
ics and conductance (67.8 + 0.8 pS, n = 6) was observed occa- 
sionally in patches on mock-transfected cells (15/94 cell-at- 
tached patches; one channel per patch) but ran down rapidly 
after excision and was not inhibited by I mM ATP (6/6 patches). 
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Fig. 3. (A,i) Whole-cell currents recorded before deft), during (centre) and alter (right) addition of 5 mM barium to the external solution, from a 
HEK293 cell transfected with Kir 6.2 + SUR. (A.ii) F V relationships recorded for the same cell in control solution (o, o), or in the presence of 5 mM 
barium (D). (B,i) Whole-cell currents recorded before (left), during (centre) and after (right) addition of 0.5 mM tolbutamide tothe external solution, 
from a HEK293 cell transfected with Kir 6.2 + SUR. (B,ii) Current voltage (~V) relationships recorded for the same cell in control solution (o, e), 
or in the presence of 500/IM tolbutamide (•). (C) Relationship between tolbutamide concentration a d the whole-cell current, expressed as a fraction 
of its amplitude in the absence of the drug, for a cell cotransfected with Kir6.2 + SUR. The line is the best fit of a modified Hill equation to the data, 
using least squares analysis, and gives Ke = 2.4/dM, n = 1.04 and O = 0.2. (D) Mean whole-cell Kir6.2/SUR currents recorded at -100 mV in control 
solution (C) and in the presence of 0.5 mM tolbutamide (T), 5 mM barium (B), or 20/IM quinine (Q). The number of cells is indicated above the 
bars. 
4. D iscuss ion  
The results presented here demonstrate that Kir6.2 encodes 
an inwardly-rectifying ATP-sensitive K-channel subunit which 
is strongly expressed in pancreatic fl-cells, brain, heart and 
skeletal muscle. This tissue distribution echoes that of the na- 
tive K-ATP channel [1-2] and suggests that Kir6.2 may form 
part of this channel. A similar tissue distr ibution is found for 
sulphonylurea binding [4] implying that SUR and Kit6.2 may 
couple in native cells. 
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(C,D) Single-channel currents recorded at -70 mV from the same inside-out patch as in A. 1 mM ATP (C) or 0.5 mM tolbutamide (D) were applied 
as indicated by the bars. Channel activity was reduced by 90% (C) and 97% (DI. The dashed lines indicate the zero current level. 
Although we were unable to detect a significant increase in 
whole-cell currents in HEK293 cells transfected with Kir6.2 
alone, very large currents were observed when Kir6.2 was 
cotransfected with SUR. This suggests that Kir6.2 does not 
express functional channels in HEK293 cells and that it couples 
in some way to SUR to form a functional channel complex. It 
remains unclear whether SUR simply facilitates the insertion 
of Kir6.2 into the membrane, whether it is needed for channel 
activity or whether both processes are involved. Mutations in 
SUR result in persistent hyperinsulinaemia of infancy (PHHI), 
a disease associated with unregulated insulin secretion [15]. Our 
finding that SUR is essential for functional Kir6.2 activity sug- 
gests that mutations in SUR produce a loss of K-ATP channel 
activity in PHHI  patients, which would be expected to depo- 
larise the ,B-cell and thus cause insulin secretion in the absence 
of secretagogues. Indeed. fl-cells from PHHI patients have been 
reported to lack K-ATP channel activity [16]. An obvious pos- 
sibility is that mutations in either SUR or Kir6.2 may also 
account for the decreased insulin secretion observed in non- 
insulin-dependent diabetes mellitus. 
Kir6.2/SUR currents show no time-dependent activation ki- 
netics and weak inward rectification in the presence of 1.2 mM 
intracellular Mg 2+, consistent with the fact that the second 
transmembrane r gion contains an asparagine at position 160, 
and that position 212 is occupied by serine. The equivalent 
residues are negatively charged in strong inward rectifiers [17]. 
We observed a marked time-dependent i crease in the ampli- 
tude of Kir6.2/SUR currents following dialysis with an intracel- 
lular solution containing 0.3 mM ATE but not with 5 mM 
ATP, suggesting thai the current is activated by the washout 
of  ATP from the cell. We also observed direct inhibition of 
single-channel currents by ATP applied at the inner face of the 
lnembrane. Since Kir6.2 possesses no obvious consensus e- 
quence for ATP-binding, and SUR has two ATP-binding do- 
mains [5], it is possible that ATP-sensitivity is conferred by the 
SUR subunit of the channel complex. However, in the absence 
of independent expression of Kit6.2 it will be necessary to 
mutate the nucleotide binding domains of SUR to verify this 
idea. Alternatively, a third protein, endogenously expressed in 
H EK293 cells, may confer ATP-sensitivity. 
We have found that SUR can confer sulphonylurea sensitiv- 
ity on other types of Kir channels, such as K i r l . l a  and Kir6.1, 
although it is not essential for expression of these channels 
(unpublished observations). It therefore seems likely that the 
sulphonylurea sensitivity of Kir6.2/SUR currents is conferred 
by the SUR subunit of the complex. 
The tissue distribution, single-channel conductance, kinetics, 
rectification properties, K-selectivity, inhibition by ATP and 
pharmacological properties of the Kir6.2/SUR complex are all 
consistent with those of native K-ATP channels. We conclude 
that the K-ATP channel consists of a complex of Kir6.2 and 
SUR, with Kir6.2 acting as the pore-forming subunit and SUR 
acting as a regulator subunit which confers sulphonylurea, nd 
possibly also ATP-sensitivity. 
.4 cknowledgement.g: We are indebted to Dr. S. Case-Green and Prof. E. 
Southern for providing us with oligonucleotides for sequencing. We 
thank Dr. S. Seino for the gift of Kir6.1, Drs. J. Bryan and 
L Aguilar-Bryan for the gift of SUR and Dr. S. Herbert for the gift 
of Kirl.la. We also thank Peter Proks and Andrew Moorhouse for 
assistance in some of the control experiments and Dr. Stephen Ashcroft 
344 H. Sakura et al . /FEBS Letters 377 (1995) 338-344 
for discussion. This work was supported by grants from the Wellcome 
Trust and the British Diabetic Association. FG was supported by a 
MRC Clinical Training Fellowship and CA by the Swedish Medical 
Research Council. 
References 
[1] Ashcroft, F.M. (1988) Annu. Rev. Neurosci. l l, 97 118 
[2] Ashcroft, F.M. and Ashcroft, S.J.H. (1990) Cell Sig. 2, 197 
214 
[3] Heurteaux, C., Bertaina, V., Widmann. C. and Lazdunski. M. 
(1993) Proc. Natl. Acad. Sci. USA 90, 9431 9435. 
[4] Ashcroft, F.M. and Ashcroft, S.J.H. (1992) Biochim. Biophys. 
Acta 1175, 45--59. 
[5] Aguilar-Bryan, L., Nichols, C.G., Wechsler. S.W., Clement. J.l~. 
Boyd, A.E., Gonz/dez, G., Herrera-Sosa, H., Nguy, K., Bryan. J. 
and Nelson, D.A. (1995) Science 268, 423-425. 
[6] Doupnik, C.A., Davidson, N. and Lester H.A. (1995) Curt. Op. 
Cell Biol. 5, 268 278. 
[7] Inagaki, N., Tsuura, Y., Namba, N., Masuda, K., Gonoi. T., 
Horie, M., Seino, Y., Mizuta, M. and Seino, S. (1995) J Biol 
Chem. 270, 5691 5694. 
[8] Ho, K., Nichols, C.G., Lederer, W.J., Lytton, J,, Vassilev, RM., 
Kanazirska, M.V. and Hebert, S.C. (1993) Nature 362, 31 
38. 
[9] Kubo, Y., Baldwin, T.J., Jan, Y.N. and Jan, L.Y. (1993). Nature 
362, 127 133. 
[10] Kubo, Y., Reuveny, E., Slesinger, P.A., Jan, Y.N. and Jan, L.Y. 
(1993) Nature 364, 802 806. 
[11] Bond, C.T., A, mm/il~, C., Ashfield, R., Blair, T.A., Gribble, F., 
Khan, R.N., Lee, K., Proks, R, Rowe, I.C.M., Sakura, H., 
Ashford, M.J., Adelman, J.R and Ashcroft, F.M. (1995) FEBS 
Lett. 367, 61-66. 
[12] Ashford, M.L.J., Bond, C.T., Blair, T.A. and Adelman, J.P. (1994) 
Nature 370, 456-459. 
[14] Bokvist, K., Rorsman, E and Smith, P.A. (1990) J. Physiol. 423, 
327-342. 
[15] Thomas, RM., Cote, G.J., Wohllk, N., Haddad, B., Mathew, 
RM., Rabl, W., Aguilar-Bryan, L., Gagel, R.F. and Bryan, J. 
(1995) Science 268, 425-429. 
[16] Dunne, M.J., Kane, C., Squires, EE., James, R.F.L., Johnson, 
RR.V. and Lindley, K.J. (1995) Diabetologia 38, A15. 
[17] Yang, J., Jan, Y.N. and Jan, L.Y. (1995) Neuron 14, 1047 
1054. 
